Rosiglitazone improves endothelial function in patients with type 2 diabetes treated with insulin. (Q51373235)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21576196%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Rosiglitazone improves endothelial function in patients with type 2 diabetes treated with insulin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21576196%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

0 references

1 reference

1 reference

Michail I. Papafaklis

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21576196%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Katerina Naka

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21576196%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Katerina Papathanassiou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21576196%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Aris Bechlioulis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21576196%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Konstantinos Pappas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21576196%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Nikolaos Kazakos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21576196%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Chryssanthi Kanioglou

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21576196%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Aggeliki Kostoula

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21576196%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Patra Vezyraki

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21576196%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Demetrios Makriyiannis

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21576196%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Agathocles Tsatsoulis

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21576196%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Lampros K Michalis

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21576196%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

language of work or name

English

0 references

publication date

16 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21576196%20AND%20SRC:MED&resulttype=core&format=json

Diabetes and Vascular Disease Research

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21576196%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21576196%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21576196%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

195-201

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21576196%20AND%20SRC:MED&resulttype=core&format=json

The evolving diabetes burden in the United States

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1479164111408628

Role of endothelial dysfunction in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111408628

Thiazolidinediones-improving endothelial function and potential long-term benefits on cardiovascular disease in subjects with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111408628

In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111408628

Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111408628

Effect of rosiglitazone on insulin resistance, C-reactive protein and endothelial function in non-obese young women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111408628

Pioglitazone restores endothelial function in patients with type 2 diabetes treated with insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111408628

Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111408628

Addition of pioglitazone and ramipril to intensive insulin therapy in type 2 diabetic patients improves vascular dysfunction by different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111408628

Thiazolidinediones and cardiovascular outcomes in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111408628

Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111408628

Effect of the insulin sensitizers metformin and pioglitazone on endothelial function in young women with polycystic ovary syndrome: a prospective randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111408628

Pioglitazone vs glimepiride: Differential effects on vascular endothelial function in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111408628

Effect of insulin therapy on endothelium-dependent dilation in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111408628

3.5 years of insulin therapy with insulin glargine improves in vivo endothelial function in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111408628

Insulin treatment and cardiovascular disease; friend or foe? A point of view.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111408628

Rosiglitazone and carotid IMT progression rate in a mixed cohort of patients with type 2 diabetes and the insulin resistance syndrome: main results from the Rosiglitazone Atherosclerosis Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111408628

Effect of rosiglitazone on progression of atherosclerosis: insights using 3D carotid cardiovascular magnetic resonance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111408628

Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with c

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111408628

Combination of insulin and thiazolidinedione therapy in massively obese patients with Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111408628

Dyslipidaemia in type 2 diabetes: effects of the thiazolidinediones pioglitazone and rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111408628

The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111408628

Effect of Rosiglitazone Treatment on Soluble CD40L in Patients With Type 2 Diabetes and Coronary Artery Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111408628

Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111408628

Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111408628

21 January 2018

Identifiers

DOI

10.1177/1479164111408628

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21576196%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference